Multiple Ovulation: Mechanisms, Risks, and Fertility Treatment Context
Multiple ovulation = release of >1 oocyte in a single cycle. Can be spontaneous or induced.
Spontaneous
- Natural incidence: ~1–2% cycles (dizygotic twinning rate).
- Increases with age (↑ FSH → multi-follicular recruitment), parity, BMI, genetics (maternal line).
- Ethnic variation: Highest in Yoruba (Nigeria), lowest in Asian populations.
Induced (Controlled Ovarian Stimulation — COS)
- Clomiphene citrate (CC): SERM → ↑ GnRH → ↑ FSH/LH; multi-follicular ~8–10%.
- Letrozole: Aromatase inhibitor → ↓ estrogen → ↑ FSH; lower multi-follicular rate vs CC.
- Gonadotropins (rFSH, hMG): Direct follicular stimulation; high multiple risk (20–30% twins, 1–3% triplets+). Requires intensive monitoring.
Risks of Multiple Gestation
| Complication | Twins | Singletons |
|---|---|---|
| Preterm <37w | ~60% | ~10% |
| Preterm <32w | ~10% | ~1.5% |
| Low BW <2500g | ~55% | ~6% |
| Preeclampsia | 2–3× | Baseline |
| Gestational diabetes | 2× | Baseline |
| C-section | ~75% | ~30% |
| Perinatal mortality | 4–5× | Baseline |
